Search
Anteris Technologies Global Corp
AVRAdd to Watchlist
7.650USD
+0.030+0.39%
Close 09-23 16:00（ET）
744.65MMarket Cap
LossP/E TTM
About Anteris Technologies Global Corp Company
Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
Anteris Technologies Global Corp Profile
Ticker SymbolAVR
Company nameAnteris Technologies Global Corp
IPO dateDec 13, 2024
CEOPaterson (Wayne G)
Number of employees136
Security typeOrdinary Share
Fiscal year-endDec 13
Address860 Blue Gentian Road
CityEAGAN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55121
Phone16514930606
Websitehttps://anteristech.com/
Ticker SymbolAVR
IPO dateDec 13, 2024
CEOPaterson (Wayne G)
Company Executives of Anteris Technologies Global Corp
Name
Name/Position
Position
Shareholding
Change
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
101.08K
--
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
101.08K
--
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
101.08K
--
Mr. Matthew Mcdonnell
Mr. Matthew Mcdonnell
Chief Financial Officer
Chief Financial Officer
27.78K
--
Mr. Stephen (Steve) Denaro
Mr. Stephen (Steve) Denaro
Corporate Secretary, Director
Corporate Secretary, Director
23.72K
--
Mr. Stephen (Steve) Denaro
Mr. Stephen (Steve) Denaro
Corporate Secretary, Director
Corporate Secretary, Director
23.72K
--
Mr. Stephen (Steve) Denaro
Mr. Stephen (Steve) Denaro
Corporate Secretary, Director
Corporate Secretary, Director
23.72K
--
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
Independent Director
Independent Director
17.58K
--
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
Independent Director
Independent Director
17.58K
--
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
Independent Director
Independent Director
17.58K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
101.08K
--
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
101.08K
--
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
101.08K
--
Mr. Matthew Mcdonnell
Mr. Matthew Mcdonnell
Chief Financial Officer
Chief Financial Officer
27.78K
--
Mr. Stephen (Steve) Denaro
Mr. Stephen (Steve) Denaro
Corporate Secretary, Director
Corporate Secretary, Director
23.72K
--
Mr. Stephen (Steve) Denaro
Mr. Stephen (Steve) Denaro
Corporate Secretary, Director
Corporate Secretary, Director
23.72K
--
FAQs
Who are the top five shareholders of Anteris Technologies Global Corp?
The top five shareholders of Anteris Technologies Global Corp are: Mr. David St Denis
How many institutions hold shares of Anteris Technologies Global Corp (AVR)?
As of 2026Q1, 138 institutions hold shares of Anteris Technologies Global Corp, with a combined market value of approximately 37.99M, accounting for 39.07% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 15387114.00.